The common data model (CDM) has found widespread application in healthcare studies, but its utilization in cancer research has been limited. This article describes the development and implementation strategy for Cancer Clinical Library Databases (CCLDs), which are standardized cancer-specific databases established under the Korea-Clinical Data Utilization Network for Research Excellence (K-CURE) project by the Korean Ministry of Health and Welfare. Fifteen leading hospitals and fourteen academic associations in Korea are engaged in constructing CCLDs for 10 primary cancer types. For each cancer type-specific CCLD, cancer data experts determine key clinical data items essential for cancer research, standardize these items across cancer types, and create a standardized schema. Comprehensive clinical records covering diagnosis, treatment, and outcomes, with annual updates, are collected for each cancer patient in the target population, and quality control is based on six-sigma standards. To protect patient privacy, CCLDs follow stringent data security guidelines by pseudonymizing personal identification information and operating within a closed analysis environment. Researchers can apply for access to CCLD data through the K-CURE portal, which is subject to Institutional Review Board and Data Review Board approval. The CCLD is considered a pioneering standardized cancer-specific database, significantly representing Korea’s cancer data. It is expected to overcome limitations of previous CDMs and provide a valuable resource for multicenter cancer research in Korea.

The common data model (CDM) has found widespread application in healthcare studies, but its utilization in cancer research has been limited. This article describes the development and implementation strategy for Cancer Clinical Library Databases (CCLDs), which are standardized cancer-specific databases established under the Korea-Clinical Data Utilization Network for Research Excellence (K-CURE) project by the Korean Ministry of Health and Welfare. Fifteen leading hospitals and fourteen academic associations in Korea are engaged in constructing CCLDs for 10 primary cancer types. For each cancer type-specific CCLD, cancer data experts determine key clinical data items essential for cancer research, standardize these items across cancer types, and create a standardized schema. Comprehensive clinical records covering diagnosis, treatment, and outcomes, with annual updates, are collected for each cancer patient in the target population, and quality control is based on six-sigma standards. To protect patient privacy, CCLDs follow stringent data security guidelines by pseudonymizing personal identification information and operating within a closed analysis environment. Researchers can apply for access to CCLD data through the K-CURE portal, which is subject to Institutional Review Board and Data Review Board approval. The CCLD is considered a pioneering standardized cancer-specific database, significantly representing Korea’s cancer data. It is expected to overcome limitations of previous CDMs and provide a valuable resource for multicenter cancer research in Korea.

The common data model (CDM) has found widespread application in healthcare studies, but its utilization in cancer research has been limited. This article describes the development and implementation strategy for Cancer Clinical Library Databases (CCLDs), which are standardized cancer-specific databases established under the Korea-Clinical Data Utilization Network for Research Excellence (K-CURE) project by the Korean Ministry of Health and Welfare. Fifteen leading hospitals and fourteen academic associations in Korea are engaged in constructing CCLDs for 10 primary cancer types. For each cancer type-specific CCLD, cancer data experts determine key clinical data items essential for cancer research, standardize these items across cancer types, and create a standardized schema. Comprehensive clinical records covering diagnosis, treatment, and outcomes, with annual updates, are collected for each cancer patient in the target population, and quality control is based on six-sigma standards. To protect patient privacy, CCLDs follow stringent data security guidelines by pseudonymizing personal identification information and operating within a closed analysis environment. Researchers can apply for access to CCLD data through the K-CURE portal, which is subject to Institutional Review Board and Data Review Board approval. The CCLD is considered a pioneering standardized cancer-specific database, significantly representing Korea’s cancer data. It is expected to overcome limitations of previous CDMs and provide a valuable resource for multicenter cancer research in Korea.

Purpose: Modern radiotherapy delivers radiation doses to targets within a few minutes using intricate multiple-beam segments determined with multi-leaf collimators (MLC). Therefore, we propose a scintillator-based dosimetry system capable of assessing the dosimetric and mechanical performance of intensity-modulated radiotherapy (IMRT) and volumetric-modulated arc therapy (VMAT) in real time. Methods: The dosimeter was equipped with a scintillator plate and two digital cameras. The dose distribution was generated by applying deep learning-based signal processing to correct the intrinsic characteristics of the camera sensor and a tomographic image reconstruction technique to rectify the geometric distortion of the recorded video. Dosimetric evaluations were performed using a gamma analysis against a two-dimensional array and radiochromic film measurements for 20 clinical cases. The average difference in the MLC position measurements and machine log files was tested for the applicability of the mechanical quality assurance (QA) of MLCs. Results: The agreement of the dose distribution in the IMRT and VMAT plans was clinically acceptable between the proposed system and conventional dosimeters. The average differences in the MLC positions for the IMRT/VMAT plans were 1.7010/2.8107 mm and 1.4722/2.7713 mm in banks A and B, respectively. Conclusions In this study, we developed an instantaneously interpretable real-time dosimeter for QA in a medical linear accelerator using a scintillator plate and digital cameras. The feasibility of the proposed system was investigated using dosimetric and mechanical evaluations in the IMRT and VMAT plans. The developed system has clinically acceptable accuracy in both the dosimetric and mechanical QAs of the IMRT and VMAT plans.

Purpose: Modern radiotherapy delivers radiation doses to targets within a few minutes using intricate multiple-beam segments determined with multi-leaf collimators (MLC). Therefore, we propose a scintillator-based dosimetry system capable of assessing the dosimetric and mechanical performance of intensity-modulated radiotherapy (IMRT) and volumetric-modulated arc therapy (VMAT) in real time. Methods: The dosimeter was equipped with a scintillator plate and two digital cameras. The dose distribution was generated by applying deep learning-based signal processing to correct the intrinsic characteristics of the camera sensor and a tomographic image reconstruction technique to rectify the geometric distortion of the recorded video. Dosimetric evaluations were performed using a gamma analysis against a two-dimensional array and radiochromic film measurements for 20 clinical cases. The average difference in the MLC position measurements and machine log files was tested for the applicability of the mechanical quality assurance (QA) of MLCs. Results: The agreement of the dose distribution in the IMRT and VMAT plans was clinically acceptable between the proposed system and conventional dosimeters. The average differences in the MLC positions for the IMRT/VMAT plans were 1.7010/2.8107 mm and 1.4722/2.7713 mm in banks A and B, respectively. Conclusions In this study, we developed an instantaneously interpretable real-time dosimeter for QA in a medical linear accelerator using a scintillator plate and digital cameras. The feasibility of the proposed system was investigated using dosimetric and mechanical evaluations in the IMRT and VMAT plans. The developed system has clinically acceptable accuracy in both the dosimetric and mechanical QAs of the IMRT and VMAT plans.

Purpose: Modern radiotherapy delivers radiation doses to targets within a few minutes using intricate multiple-beam segments determined with multi-leaf collimators (MLC). Therefore, we propose a scintillator-based dosimetry system capable of assessing the dosimetric and mechanical performance of intensity-modulated radiotherapy (IMRT) and volumetric-modulated arc therapy (VMAT) in real time. Methods: The dosimeter was equipped with a scintillator plate and two digital cameras. The dose distribution was generated by applying deep learning-based signal processing to correct the intrinsic characteristics of the camera sensor and a tomographic image reconstruction technique to rectify the geometric distortion of the recorded video. Dosimetric evaluations were performed using a gamma analysis against a two-dimensional array and radiochromic film measurements for 20 clinical cases. The average difference in the MLC position measurements and machine log files was tested for the applicability of the mechanical quality assurance (QA) of MLCs. Results: The agreement of the dose distribution in the IMRT and VMAT plans was clinically acceptable between the proposed system and conventional dosimeters. The average differences in the MLC positions for the IMRT/VMAT plans were 1.7010/2.8107 mm and 1.4722/2.7713 mm in banks A and B, respectively. Conclusions In this study, we developed an instantaneously interpretable real-time dosimeter for QA in a medical linear accelerator using a scintillator plate and digital cameras. The feasibility of the proposed system was investigated using dosimetric and mechanical evaluations in the IMRT and VMAT plans. The developed system has clinically acceptable accuracy in both the dosimetric and mechanical QAs of the IMRT and VMAT plans.

Purpose: Modern radiotherapy delivers radiation doses to targets within a few minutes using intricate multiple-beam segments determined with multi-leaf collimators (MLC). Therefore, we propose a scintillator-based dosimetry system capable of assessing the dosimetric and mechanical performance of intensity-modulated radiotherapy (IMRT) and volumetric-modulated arc therapy (VMAT) in real time. Methods: The dosimeter was equipped with a scintillator plate and two digital cameras. The dose distribution was generated by applying deep learning-based signal processing to correct the intrinsic characteristics of the camera sensor and a tomographic image reconstruction technique to rectify the geometric distortion of the recorded video. Dosimetric evaluations were performed using a gamma analysis against a two-dimensional array and radiochromic film measurements for 20 clinical cases. The average difference in the MLC position measurements and machine log files was tested for the applicability of the mechanical quality assurance (QA) of MLCs. Results: The agreement of the dose distribution in the IMRT and VMAT plans was clinically acceptable between the proposed system and conventional dosimeters. The average differences in the MLC positions for the IMRT/VMAT plans were 1.7010/2.8107 mm and 1.4722/2.7713 mm in banks A and B, respectively. Conclusions In this study, we developed an instantaneously interpretable real-time dosimeter for QA in a medical linear accelerator using a scintillator plate and digital cameras. The feasibility of the proposed system was investigated using dosimetric and mechanical evaluations in the IMRT and VMAT plans. The developed system has clinically acceptable accuracy in both the dosimetric and mechanical QAs of the IMRT and VMAT plans.

Purpose: Modern radiotherapy delivers radiation doses to targets within a few minutes using intricate multiple-beam segments determined with multi-leaf collimators (MLC). Therefore, we propose a scintillator-based dosimetry system capable of assessing the dosimetric and mechanical performance of intensity-modulated radiotherapy (IMRT) and volumetric-modulated arc therapy (VMAT) in real time. Methods: The dosimeter was equipped with a scintillator plate and two digital cameras. The dose distribution was generated by applying deep learning-based signal processing to correct the intrinsic characteristics of the camera sensor and a tomographic image reconstruction technique to rectify the geometric distortion of the recorded video. Dosimetric evaluations were performed using a gamma analysis against a two-dimensional array and radiochromic film measurements for 20 clinical cases. The average difference in the MLC position measurements and machine log files was tested for the applicability of the mechanical quality assurance (QA) of MLCs. Results: The agreement of the dose distribution in the IMRT and VMAT plans was clinically acceptable between the proposed system and conventional dosimeters. The average differences in the MLC positions for the IMRT/VMAT plans were 1.7010/2.8107 mm and 1.4722/2.7713 mm in banks A and B, respectively. Conclusions In this study, we developed an instantaneously interpretable real-time dosimeter for QA in a medical linear accelerator using a scintillator plate and digital cameras. The feasibility of the proposed system was investigated using dosimetric and mechanical evaluations in the IMRT and VMAT plans. The developed system has clinically acceptable accuracy in both the dosimetric and mechanical QAs of the IMRT and VMAT plans.

Purpose: High-dose radiotherapy (RT) for localized prostate cancer requires careful consideration of target position changes and adjacent organs-at-risk (OARs), such as the rectum and bladder. Therefore, daily monitoring of target position and OAR changes is crucial in minimizing interfractional dosimetric uncertainties. For efficient monitoring of the internal condition of patients, we assessed the feasibility of an auto-segmentation of OARs on the daily acquired images, such as megavoltage computed tomography (MVCT), via a commercial artificial intelligence (AI)-based solution in this study. Materials and Methods: We collected MVCT images weekly during the entire course of RT for 100 prostate cancer patients treated with the helical TomoTherapy system. Based on the manually contoured body outline, the bladder including prostate area, and rectal balloon regions for the 100 MVCT images, we trained the commercially available fully convolutional (FC)-DenseNet model and tested its auto-contouring performance. Results: Based on the optimally determined hyperparameters, the FC-DenseNet model successfully auto-contoured all regions of interest showing high dice similarity coefficient (DSC) over 0.8 and a small mean surface distance (MSD) within 1.43 mm in reference to the manually contoured data. With this well-trained AI model, we have efficiently monitored the patient's internal condition through six MVCT scans, analyzing DSC, MSD, centroid, and volume differences. Conclusion We have verified the feasibility of utilizing a commercial AI-based model for auto-segmentation with low-quality daily MVCT images. In the future, we will establish a fast and accurate auto-segmentation and internal organ monitoring system for efficiently determining the time for adaptive replanning.

Purpose: Clinical nurses who are mothers of preschool-aged children experience extreme parenting stress linked to their hospital work environment and shift work, differing from that generally experienced by mothers. This study aimed to develop and validate a parenting stress scale that considers the clinical nurses’ form of work and its characteristics. Methods: The scale items were initially derived from in-depth interviews and a literature review and were revised and modified based on the results of content validity testing by experts. The developed instrument was evaluated using data from 157 clinical nurses in South Korea who were mothers of preschool-aged children. Results: In the instrument validation stage, 19 items categorized in four factors (psychological burden, physical and mental fatigue, work shift, and work environment) were derived from construct validity, and the cumulative explanatory power was 56.6%. Furthermore, the convergent and discriminant validity and external construct were confirmed. Cronbach’s α of the final instrument was .86 (range: .81–.86). The validity and reliability of the newly developed parenting stress scale for clinical nurses were established in this study; it uses a 4-point Likert scale. A higher mean score by factor indicates a higher level of parenting stress experienced by clinical nurses. Conclusion This instrument would be beneficial to measure the level of parenting stress among nurses who work in hospitals and evaluate factors related to their parenting stress to devise effective interventions.